Literature DB >> 7712697

Comparing the incidence of lower extremity amputations across the world: the Global Lower Extremity Amputation Study.

.   

Abstract

A substantial proportion of lower extremity amputations (LEAs), particularly in people with diabetes, are thought to be preventable by the provision of appropriate health care. Information on the incidence of LEAs which is accurate, up-to-date, and comparable cross-sectionally and longitudinally is essential to guide and monitor interventions aimed at their prevention. Current information on the incidence of LEAs is limited and differences between studies in case definition, presentation of rates, level of ascertainment, and population age structure often make meaningful comparisons impossible. To remedy this situation the global LEA study has been established. The study is designed to compare the incidence of LEAs over time within and between communities across the world. The methodology includes adherence to a standard definition of LEA, standardized methods of data collection with built-in quality control, and correction for under-ascertainment of cases (using capture-recapture methodology). Centres wishing to take part in the study must be able to identify a study population of at least 250,000, have reasonably up-to-date population numbers by age and sex, and be prepared to stay in the study for at least 2 years. A study registration form (Appendix 1) is provided.

Entities:  

Mesh:

Year:  1995        PMID: 7712697

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Differences in the diagnosis and management of type 2 diabetes in 3 countries (US, UK, and Germany): results from a factorial experiment.

Authors:  Olaf von dem Knesebeck; Eric Gerstenberger; Carol Link; Lisa Marceau; Martin Roland; Stephen Campbell; Johannes Siegrist; Werner de Cruppé; John McKinlay
Journal:  Med Care       Date:  2010-04       Impact factor: 2.983

Review 2.  The cost of diabetic foot problems.

Authors:  J D Ward
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

Review 3.  Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always.

Authors:  Alok Raghav; Zeeshan Ahmad Khan; Rajendra Kumar Labala; Jamal Ahmad; Saba Noor; Brijesh Kumar Mishra
Journal:  Ther Adv Endocrinol Metab       Date:  2017-12-12       Impact factor: 3.565

4.  Relationship Between Neutrophil/Albumin Ratio and Early Mortality After Major Lower Extremity Amputation.

Authors:  Ali Eray Günay; Mehmet Ekici
Journal:  Cureus       Date:  2021-09-05

5.  Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON.

Authors:  Sandra Y Silva; Ligia C Rueda; Gustavo A Márquez; Marcos López; Daniel J Smith; Carlos A Calderón; Juan C Castillo; Jaime Matute; Christian F Rueda-Clausen; Arturo Orduz; Federico A Silva; Piyaporn Kampeerapappun; Mahesh Bhide; Patricio López-Jaramillo
Journal:  Trials       Date:  2007-09-26       Impact factor: 2.279

6.  Clinical Characteristics and Risk Factor Analysis for Lower-Extremity Amputations in Diabetic Patients With Foot Ulcer Complicated by Necrotizing Fasciitis.

Authors:  I-Wen Chen; Hui-Mei Yang; Cheng-Hsun Chiu; Jiun-Ting Yeh; Chung-Huei Huang; Yu-Yao Huang
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.